FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leslie Amass

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Activities & Behaviors

Co-author Network

Publications

TOP 3
Leslie Amass; António Costa; Pietro D'Egidio; Maria Chiara Pieri; Vilma Pukeleviciene; Slavko Sakoman; Bobby P Smyth; Zdenka Stankova; Emilis Subata; Yan Wei; António Rocha Almeida; John Strang
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
Rhodri Dierst-Davies; Cathy J Reback; James A Peck; Miriam Nuño; Jonathan B Kamien; Leslie Amass
Delay-discounting among homeless, out-of-treatment, substance-dependent men who have sex with men.
Cathy J Reback; James A Peck; Rhodri Dierst-Davies; Miriam Nuno; Jonathan B Kamien; Leslie Amass
Contingency management among homeless, out-of-treatment men who have sex with men.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leslie Amass (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Leslie Amass; António Costa; Pietro D'Egidio; Maria Chiara Pieri; Vilma Pukeleviciene; Slavko Sakoman; Bobby P Smyth; Zdenka Stankova; Emilis Subata; Yan Wei; António Rocha Almeida; John Strang
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
Addiction (Abingdon, England) 2012;107(1):142-51.
2011: Rhodri Dierst-Davies; Cathy J Reback; James A Peck; Miriam Nuño; Jonathan B Kamien; Leslie Amass
Delay-discounting among homeless, out-of-treatment, substance-dependent men who have sex with men.
The American journal of drug and alcohol abuse 2011;37(2):93-7.
2010: Cathy J Reback; James A Peck; Rhodri Dierst-Davies; Miriam Nuno; Jonathan B Kamien; Leslie Amass
Contingency management among homeless, out-of-treatment men who have sex with men.
Journal of substance abuse treatment 2010;39(3):255-63.
2010: Sandra D Comer; Maria A Sullivan; Suzanne K Vosburg; Jeanne Manubay; Leslie Amass; Ziva D Cooper; Phillip Saccone; Herbert D Kleber
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.
Addiction (Abingdon, England) 2010;105(4):709-18.
2009: Douglas M Ziedonis; Leslie Amass; Marc Steinberg; George Woody; Jonathan Krejci; Jeffrey J Annon; Allan J Cohen; Nancy Waite-O'Brien; Susan Marie Stine; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Robert Maslansky; Theresa Winhusen; Dean Babcock; Greg Brigham; Joan Muir; Deborah Orr; Betty J Buchan; Terry Horton; Walter Ling
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
Drug and alcohol dependence 2009;99(1-3):28-36.
2008: Steven A Branstetter; Emily H Bower; Jonathan Kamien; Leslie Amass
A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment.
Journal of substance abuse treatment 2008;34(2):208-14.
2007: James W Finch; Jonathan B Kamien; Leslie Amass
Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting.
Journal of addiction medicine 2007;1(2):104-10.
2007: Greg Brigham; Leslie Amass; Theresa M Winhusen; Judy M Harrer; Alvin Pelt
Using buprenorphine short-term taper to facilitate early treatment engagement.
Journal of substance abuse treatment 2007;32(4):349-56.
2007: Eric D Collins; Terry Horton; Katherine Reinke; Leslie Amass; Edward V Nunes
Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
Journal of substance abuse treatment 2007;32(2):167-75.
2007: Cathy J Reback; Jonathan B Kamien; Leslie Amass
Characteristics and HIV risk behaviors of homeless, substance-using men who have sex with men.
Addictive behaviors 2007;32(3):647-54.
2006: Maria Patrizia Carrieri; Leslie Amass; Gregory M Lucas; David Vlahov; Alex Wodak; George E Woody
Buprenorphine use: the international experience.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S197-215.
2005: Walter Ling; Leslie Amass; Steven Shoptaw; Jeffrey J Annon; Maureen P Hillhouse; Dean Babcock; Greg Brigham; Judy M Harrer; Malcolm Reid; Joan Muir; Betty Buchan; Debbie Orr; George Woody; Jonathan Krejci; Douglas M Ziedonis
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.
Addiction (Abingdon, England) 2005;100(8):1090-100.
2004: Leslie Amass; Jonathan B Kamien
A tale of two cities: financing two voucher programs for substance abusers through community donations.
Experimental and clinical psychopharmacology 2004;12(2):147-55.
2004: Leslie Amass; Walter Ling; Thomas E Freese; Chris Reiber; Jeffrey J Annon; Allan J Cohen; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Cynthia Clark; Douglas M Ziedonis; Jonathan Krejci; Susan Marie Stine; Theresa M Winhusen; Greg Brigham; Dean Babcock; Joan A Muir; Betty J Buchan; Terry Horton
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13 Suppl 1():S42-66.
2003: Rolley E. Johnson; Eric C Strain; Leslie Amass
Buprenorphine: how to use it right.
Drug and alcohol dependence 2003;70(2 Suppl):S59-77.
2002: Catherine Stanger; Jody Kamon; Levent Dumenci; Stephen T Higgins; Warren K Bickel; John Grabowski; Leslie Amass
Predictors of internalizing and externalizing problems among children of cocaine and opiate dependent parents.
Drug and alcohol dependence 2002;66(2):199-212.
2001: Lawrence E Adler; Ann Olincy; Ellen M Cawthra; M Hoffer; Herbert T Nagamoto; Leslie Amass; Robert Freedman
Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(6):671-9.
2001: Leslie Amass; Jonathan B Kamien; Susan K Mikulich
Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans.
Drug and alcohol dependence 2001;61(2):173-81.
2000: Leslie Amass; Jonathan B Kamien; Susan K Mikulich
Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet.
Drug and alcohol dependence 2000;58(1-2):143-52.
1999: Warren K Bickel; Leslie Amass; J P Crean; Gary J Badger
Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients.
Psychopharmacology 1999;146(2):111-8.
1999: Catherine Stanger; Stephen T Higgins; Warren K Bickel; R Elk; John Grabowski; Joy Schmitz; Leslie Amass; Kimberly Kirby; A M Seracini
Behavioral and emotional problems among children of cocaine- and opiate-dependent parents.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(4):421-8.
1998: Alan J Budney; Warren K Bickel; Leslie Amass
Marijuana use and treatment outcome among opioid-dependent patients.
Addiction (Abingdon, England) 1998;93(4):493-503.
1998: Leslie Amass; Warren K Bickel; J P Crean; J Blake; Stephen T Higgins
Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans.
Psychopharmacology 1998;136(3):217-25.
1997: Warren K Bickel; Leslie Amass; Stephen T Higgins; Gary J Badger; R A Esch
Effects of adding behavioral treatment to opioid detoxification with buprenorphine.
Journal of consulting and clinical psychology 1997;65(5):803-10.
1997: David E Moody; John D Laycock; Alan C Spanbauer; Dennis Crouch; Rodger L Foltz; J L Josephs; Leslie Amass; Warren K Bickel
Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 1997;21(6):406-14.
1996: Leslie Amass; Warren K Bickel; J P Crean; Stephen T Higgins; Gary J Badger
Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program.
Journal of substance abuse treatment 1996;13(1):43-9.
1994: Leslie Amass; Warren K Bickel; Stephen T Higgins; Gary J Badger
Alternate-day dosing during buprenorphine treatment of opioid dependence.
Life sciences 1994;54(17):1215-28.
1994: Leslie Amass; Warren K Bickel; Stephen T Higgins; John R Hughes
A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification.
Journal of addictive diseases 1994;13(3):33-45.
1993: Leslie Amass; Warren K Bickel; Stephen T Higgins; Alan J Budney; F E Foerg
The taking of free condoms in a drug abuse treatment clinic: the effects of location and posters.
American journal of public health 1993;83(10):1466-8.
1993: Warren K Bickel; Leslie Amass
The relationship of mean daily blood alcohol levels to admission MAST, clinic absenteeism and depression in alcoholic methadone patients.
Drug and alcohol dependence 1993;32(2):113-8.
1992: Leslie Amass; R Nardin; J H Mendelson; S K Teoh; B T Woods
Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: a preliminary study.
Psychiatry research 1992;45(1):15-23.